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Introduction
Copper is an essential trace element for many biological processes, including mitochondrial respiration, iron metabolism, detoxification of free radicals and crosslinking of connective tissue (Bonham et al., 2002) . Disruption of copper homeostasis is associated with many human diseases, particularly liver diseases. Excessive copper accumulation in the liver secondary to cholestasis has been well documented in patients with primary biliary cirrhosis (Deering et al., 1977) , as well as in alcoholic cirrhotics (Rodríguez-Moreno et al., 1997) and experimental fibrosis (Schaff et al., 1991) .
Conversely, copper is decreased in the early stage of some liver diseases, such as alcoholic steatosis (Uhlikova et al., 2008) , non-alcoholic fatty liver disease (NAFLD) (Aigner et al., 2008 and 2010) , and acute experimental liver injury (Domitrović et al., 2008) . Therefore, maintaining normal copper homeostasis could be an important therapeutic target for liver diseases.
JPET #184325 8 metal grade nitric acid (Fisher Scientific, Pittsburgh, PA) . Plasma ferritin was determined by commercially available kit (ALPCO Diagnostics, Salem, NH).
Liver Enzyme Assay
Plasma alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), and total bilirubin assays were performed with commercially available kits (Infinity, Thermo Electron Corp., Melbourne, Australia) based on a colorimetric method.
Histology and Immunohistochemistry
Formalin-fixed, paraffin-embedded liver sections were cut at a 3 µm thickness. Liver injury was determined by staining with hematoxylin and eosin (H&E) . Extracellular matrix accumulation in liver sections was determined by staining with Masson's trichrome and Sirius red-fast green. The area in the liver section of positive Sirius red staining was quantified using MetaMorph software (Universal Imaging Corporation, Downingtown, PA). Specifically, a Molecular Devices (Sunnyvale, CA) Image-1/AT image acquisition and analysis system incorporating an Axioskop 50 microscope (Carl Zeiss Inc., Thornwood, NY) was used to capture and analyze eight non-overlapping fields per section at 400×magnification. Data from each section were pooled to determined means. Image analysis was performed using techniques described previously (Bergheim et al., 2006) . visualized using the horseradish peroxidase-conjugated DAKO staining system (DAKO InVision, Carpenteria, CA).
Isolation of RNA and Real Time RT-PCR
Total RNA was extracted from liver tissues using TRIZOL (Invitrogen, Carlsbad, CA) according to the manufacturer's protocol. For real-time RT-PCR, the first-strand cDNA was synthesized using TaqMan Reverse transcription reagents (Applied Biosystems, Foster City, CA). The reverse transcription was carried out using 1×Taqman RT buffer, 5.5mM MgCl 2 , 500 mM of each dNTP, 2.5 mM random hexamer, 8 U of RNase inhibitor and 25 U of Multiscribe Reverse Transcriptase with 200 ng of total RNA. The RT conditions were 10 minutes at 25°C, 30 minutes at 48°C and 5 minutes at 95°C. Realtime PCR was performed with an ABI prism 7500 sequence detection system and reactions were prepared using SYBR green master mix (Applied Biosystems, Foster City, CA). Primers were designed and synthesized by SABiosciences (SABiosciences, Frederick, MD) (Genbank Accession Number, see Table 1 ). The parameter Ct (threshold cycle) was defined as the fraction cycle number at which the fluorescence passed the threshold. The relative gene expression was analyzed using 2 -ΔΔCt method (Livak and Schmittgen, 2001 ) by normalizing with 18Sr RNA gene expression in all the experiments.
Western Blot
Hepatic nuclear and cytosol segments were extracted by using commercial available kit (Active Motif, Carlsbad, CA). Equal amounts of protein were loaded and resolved on 10% SDS-polyacrylamide gels, transferred to polyvinylidene difluoride (PVDF) membrane (Millipore Corporation, Billerica, MA). The membrane was blocked and probed with primary antibody for copper chaperone for SOD1 (CCS) (dilution 1:500), This article has not been copyedited and formatted. The final version may differ from this version. 
Hepatic GSH/GSSG and SAM Assay
Reduced glutathione (GSH), oxidized glutathione (GSSG) and S-adenosylmethionine (SAM) were determined by HPLC.
Statistical Analysis
Results are expressed as mean ± SD (Standard Deviation). Statistical analysis was performed using one-way ANOVA followed by Newman-Keuls' Multiple Comparison Test. P < 0.05 was considered statistically significant.
This article has not been copyedited and formatted. The final version may differ from this version. 
Metabolites
After 2 weeks BDL, body weight gain was significantly decreased compared to sham operated rats. Both body weight and body weight gain were significantly decreased by TM-induced copper deficiency in BDL rats; however, they were not significantly affected by TM treatment in sham operated rats. Liver weight and liver/body weight ratio were significantly increased after BDL, and they were further increased by copper deficiency.
Similarly, plasma cholesterol was significantly higher in BDL rats compared to sham operated rats, and it was further increased by TM-induced copper deficiency, which is a typical sign associated with copper deficiency (Table 2 ).
Copper and Iron Status
As expected, the plasma ceruloplasmin level was significantly elevated (approximately 2.5 fold) in the rats after two weeks BDL. Conversely, the plasma ceruloplasmin was significantly decreased in both sham and BDL animals treated TM compared to animals with sham operation only (about 8% and 3% of baseline, respectively) (Fig. 1A) . Liver copper was significantly increased in BDL rats compared to sham animals, and it was significantly decreased in BDL plus TM rats compared to BDL animals ( Fig.1 B) . As an indicator of copper status (Harvey and McArdle, 2008) , hepatic CCS expression was up-regulated by copper deficiency, and negatively related to the liver copper and plasma ceruloplasmin level, as shown by Western Blot (Fig.1 C) . All of the data above suggested that biologically available copper was severely deficient in TM treated animals. The plasma ferritin, a marker of total body iron stores, was robustly increased (approximately 13 fold) in BDL rats treated with TM compared to controls ( Fig.1 D) . Liver iron was also significantly increased in both sham and BDL rats treated TM compared to control ( Fig.1 E) .
Copper Deficiency Exacerbated BDL-Induced Cholestatic Liver Injury
Liver injury was assessed by plasma liver enzymes (ALT, AST, and ALP), total bilirubin, and histology. The plasma ALT, AST and ALP levels were not significantly changed by TM-induced copper deficiency in sham-operated rats compared to controls.
After two weeks BDL, plasma ALT, AST and ALP were slightly elevated (differences did not reach statistical significance). However, TM-induced copper deficiency led to a significant increase in plasma ALT level by 2-fold in BDL rats compared with shamoperated animals ( Fig.2 A) . The plasma AST level was robustly increased by approximately 4-fold and 2-fold respectively in BDL plus TM rats compared to sham and BDL animals ( Fig.2 B) . Similarly, the plasma ALP and total bilirubin were also significantly elevated in copper deficient BDL rats compared to controls ( Fig.3 A and B) . Quantification of Sirius red staining by image analysis showed that collagen content was robustly increased (5-fold) in the livers of BDL rats, and it was further significantly increased (8-fold) with TM-induced copper deficiency compared to controls (Fig.3D ).
TM-Induced Copper Deficiency Aggravated Hepatic Fibrosis Induced by BDL
We further evaluated fibrogenesis by immunohistochemistry staining for α -SMA, a marker of hepatic stellate cell activation. Compared with controls, α -SMA expression was markedly increased in the livers of BDL rats, and it was further enhanced by TMinduced copper deficiency, suggesting enhanced fibrogenesis (Fig.3 C) . Taken together, our data clearly showed that copper deficiency aggravated BDL-induced liver fibrosis, which paralleled the severity of liver injury.
TM-Induced Copper Deficiency Inhibited Hepatic Gene Expression Involved in Mitochondrial Biogenesis and Fatty Acid β -Oxidation
This article has not been copyedited and formatted. The final version may differ from this version. Data from liver enzyme assays suggested that mitochondrial impairment is a likely potential mechanism involved in copper deficiency associated liver injury. To further evaluate mitochondrial function, the gene expression implicated in mitochondria biogenesis and fatty acid β -oxidation was determined by real time RT-PCR (Fig.4) . Our data showed that the mRNA expression of the mitochondrial transcription factor B1(Tfb1m), a transcription factor which is necessary for basal transcription of mammalian mitochondrial DNA (mtDNA) (Falkenberg et al., 2002) , was significantly up-regulated more than 2-fold in the livers of BDL rats, and this was abrogated in copper deficient BDL rats. The mRNA expression of the key genes regulating fatty acid oxidation, such as, PPAR-α, Cpt1a and Hmgcs2, was significantly increased in BDL rat liver, whereas this increase was blocked in copper deficient BDL rat.
Increased Oxidative Stress and Decreased Antioxidant Defense by TM-Induced Copper Deficiency in BDL Rats
To evaluate the possible effects of BDL and copper deficiency on oxidative stress, GSH/GSSG ratio, S-adenosylmethionine (SAM) and 4-HNE were determined. A significant increase in GSH/GSSG ratio (Fig.5 A) was observed, suggesting a response to more oxidative stress in copper deficient BDL rats. Hepatic SAM, a precursor of GSH synthesis, was also significantly decreased in copper deficient BDL rats (Fig.5 B) . SODs are important antioxidant defenses against oxidative stress. SOD1, a cuproenzyme, is mainly distributed in the cytosol, and in the inter-membrane space of mitochondria (Okado-Matsumoto and Fridovich, 2001) . SOD2 is located in the mitochondria. Hepatic SOD1 expression was significantly down-regulated in both sham and BDL rats in response to TM-induced copper deficiency, as shown by Western Blot (Fig.5 C) . 
Discussion
Our previous data have demonstrated that lowering copper to 30% of basal level protected against BDL-induced liver fibrosis (Song et al., 2008) . However, when copper is severely deficient (<8% of baseline in terms of ceruloplasmin) ( Figure 1A) , it exacerbated BDL-induced liver injury and liver fibrosis. Sprague-Dawley (SD) rats are known to be a sensitive model in response to copper deficiency, and low dose TM (10 mg/kg/day) depleted copper to a greater extent in the SD rat than it did in our previous mouse model (Song et al., 2008) . It appeared that the severity of liver fibrosis paralleled the severity of liver injury and hepatic stellate cell activation in rats subjected to BDL and severe copper deficiency, suggesting that liver injury is the primary event in the liver fibrosis induced by copper deficiency and BDL. Moreover, liver injury in BDL rats resulting from copper deficiency is characterized by robustly increased plasma AST ( Figure 2B ), suggesting potential mitochondrial impairment (Panteghini, 1990) . In fact, previous work has shown that both acute and chronic severe copper deficiency led to abnormal mitochondria (Gallagher et al., 1973) . However, the underlying mechanism(s)
are not fully understood.
One of the principal cuproenzymes, cytochrome c oxidase, is the terminal enzyme of mitochondrial respiratory chain. Another cuproenzyme, SOD1, is an important antioxidant defense against oxidative stress. The distribution of SOD1 is mainly in the cytosol, and it has also been found in the inter-membrane space of mitochondria (OkadoMatsumoto and Fridovich, 2001) . It is well documented that activity of both cytochrome c oxidase and SOD1 were decreased by copper deficiency (Johnson and DeMars, 2004; Prohaska, 1991) . Consistent with previous studies, our data also showed that hepatic This article has not been copyedited and formatted. The final version may differ from this version. et al., 1999) . Our data clearly showed extremely low plasma ceruloplasmin activity in both sham and BDL animals induced by TM ( Figure 1A ).
Iron plays an essential role in the maintenance of mitochondria, through its two major Maintaining mitochondrial homeostasis involves biogenesis and replacement.
Therefore, we further evaluated mitochondrial biogenesis by determining the related gene expression. We found that the mRNA expression of mitochondrial transcription factor B1(Tfb1m), a transcription factor which is necessary for basal transcription of mammalian mitochondrial DNA (mtDNA) (Falkenberg et al., 2002) , was significantly up-regulated more than 2-fold in the livers of BDL rats, and this was abrogated in copper deficient BDL rats. Similarly, the mRNA expression of the key genes regulating fatty acid β -oxidation, such as, PPAR-α (Shalev et al., 1996 ), Cpt1a (Akkaoui et al., 2009 ) and Hmgcs2 (Kostiuk et al., 2008 were significantly increased in BDL rat livers, whereas this increase was blocked in copper deficient BDL rats. A recent study showed that mitochondrial biogenesis may be regulated by HO-1 in heart (Piantadosi et al., 2008) , which may also explain our results. Taken together, it appears that disruption of mitochondrial biogenesis is another likely mechanism by which copper deficiency exacerbates liver injury in BDL rats.
Previous work showed that the activity of hepatic HO-1 in rats is elevated in response to 5 weeks copper deficiency (Johnson and DeMars, 2004) . Our data showed that hepatic This article has not been copyedited and formatted. The final version may differ from this version. Tables   Table 1 Genbank Accession Number Tfb1m, transcription factor B1, mitochondrial; Hmgcs2, 3-hydroxy-3-methylglutaryl- Table 2 Effects of TM and BDL on Body Weight, Liver Weight, and Plasma Cholesterol
Seven weeks old male Sprague-Dawley rats were given either BDL or sham operation. TM was given in a daily dose of 10mg/kg/day by means of intragastric gavage beginning 5 days after surgery. All animals were killed 2 weeks after surgery.
Data are shown as means ± SD (n=5-6). *, significantly different from sham group. †, significantly different from BDL group. BDL, bile duct ligation; TM, tetrathiomolybdate. 
